OK Biotech Co., Ltd. (TWSE: 4155)
Health Care · Health Care Equipment & Supplies · TW
NT$14.20
-4.38% today · -3.1% 1Y
OK Biotech Co., Ltd. (TWSE: 4155) operates in the Health Care Equipment & Supplies industry within the Health Care sector. The company is valued at $61.26M and employs 62 people.
Over the last twelve months the share price has lost 3.1%, trading between 12.85 and 16.50.
Tweenvest scores OK Biotech Co., Ltd. across four factors: quality 69/100, value 63/100, growth 30/100, dividend 59/100. Its strongest factor is quality.
4155 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $61.26M
- Revenue (TTM)
- $48.31M
- P/E
- 8.49
- EPS
- 1.67
- Dividend yield
- 2.11%
- Beta (5Y)
- 0.26
- 52-week high
- NT$16.50
- 52-week low
- NT$12.85
- Avg volume (3M)
- —
- Shares outstanding
- 137.17M
- Employees
- 62
- Next earnings
- —
About OK Biotech Co., Ltd.
OK Biotech Co., Ltd., established in 2006 and based in Hsinchu City, Taiwan, is a global producer and vendor of blood glucose meters. Its product line further encompasses nebulizers, glucometers, blood sugar meters, blood glucose test strips, and personal sound amplifiers.
- ISIN
- TW0004155007
- Founded
- 2004
- Listed since
- Jun 20, 2012
- Exchange
- Taiwan Stock Exchange
- Currency
- TWD
Other Health Care Equipment & Supplies companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Gentian Diagnostics ASAOB: GENT | $63.02M | Nkr38.50 | -1.28% |
| Creo Medical Group PLCAIM: CREO | $62.28M | £0.11 | 0.00% |
| Abingdon Health PlcAIM: ABDX | $61.89M | £0.11 | 0.00% |
| Austco Healthcare LimitedASX: AHC | $61.46M | AU$0.24 | -6.00% |
| Venus Medtech (Hangzhou) Inc.SEHK: 2500 | $61.10M | HK$1.10 | -8.37% |
| Daxor CorporationNasdaqCM: DXR | $60.78M | $10.49 | +0.77% |
| Vincent Medical Holdings LimitedSEHK: 1612 | $60.56M | HK$0.72 | +6.67% |
| Corentec Co., Ltd.KOSDAQ: A104540 | $59.14M | ₩5,930.00 | +15.15% |
Figures last refreshed Oct 11, 2026.